Pfs Partners, LLC Viatris Inc Transaction History

Pfs Partners, LLC

$210 Billion
Q3 2025

A detailed history of Pfs Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Pfs Partners, LLC holds 234 shares of VTRS stock, worth $2,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares

234

Previous 208 12.5%

Holding current value

$2,508

Previous $1.86 Million 24.74%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	BUY	$8.74 - $10.69 $227 - $277	26 Added 12.5%	234 $2.32 Million
Q2 2025 Jul 16, 2025	BUY	$7.26 - $9.12 $14 - $18	2 Added 0.97%	208 $1.86 Million
Q1 2025 Apr 14, 2025	BUY	$8.68 - $12.42 $17 - $24	2 Added 0.98%	206 $1.79 Million
Q4 2024 Jan 24, 2025	SELL	$11.32 - $13.37 $645 - $762	-57 Reduced 21.84%	204 $2.54 Million
Q3 2024 Nov 01, 2024	SELL	$10.32 - $12.13 $433 - $509	-42 Reduced 13.86%	261 $3.04 Million

Q2 2024 Jul 25, 2024	BUY	$10.05 - $12.02 $20 - $24	2 Added 0.66%	303 $3.22 Million
Q1 2024 Apr 15, 2024	BUY	$11.27 - $13.53 $507 - $608	45 Added 17.58%	301 $3.59 Million
Q4 2023 Jan 26, 2024	BUY	$8.77 - $10.85 $657 - $813	75 Added 41.44%	256 $2.78 Million
Q3 2023 Nov 30, 2023	BUY	$9.59 - $11.35 $9 - $11	1 Added 0.56%	181 $1.79 Million
Q2 2023 Nov 30, 2023	BUY	$9.02 - $10.29 $9 - $10	1 Added 0.56%	180 $1.8 Million
Q1 2023 Nov 30, 2023	BUY	$9.2 - $12.26 $9 - $12	1 Added 0.56%	179 $1.73 Million
Q2 2022 Nov 30, 2023	BUY	$9.95 - $12.27 $9 - $12	1 Added 0.56%	178 $1.86 Million
Q1 2022 Nov 30, 2023	BUY	$9.81 - $15.4 $451 - $708	46 Added 35.11%	177 $1.92 Million
Q4 2021 Nov 30, 2023	BUY	$12.09 - $14.68 $1,583 - $1,923	131 New	131 $1.77 Million

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

970M

Call Options Held

7.74M

Put Options Held

2.47M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.

Account